Poll

Mini Quiz: Schizophrenia Research

Author(s):

Brian Miller, MD, PhD, MPH

Current trials are investigating adjunctive monoclonal antibody immunotherapy in schizophrenia. Take the quiz and learn more.

Current trials are investigating adjunctive monoclonal antibody immunotherapy in schizophrenia with all of the following agents EXCEPT:

A. Adalimumab
B. Canakinumab
C. Siltuximab
D. Tocilizumab
E. Natalizumab
Related Videos
Meyer
emergency
schizophrenia
sc
schizophrenia
clozapine
brain
cognition
clock
Related Content
schizophrenia
May 22nd 2025

Major Changes in the Treatment of Schizophrenia: A Long Time in the Making

Peter J. Weiden, MD
Treating ‘Morally Objectionable’ Patients
September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD
brain
May 12th 2025

Phase 3 Development Plan for Evenamide as Add-On Therapy for Treatment-Resistant Schizophrenia

Leah Kuntz
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle
May 11th 2021

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

Anita H. Clayton, MD
dawn
May 7th 2025

The Dawn of a New Era for Schizophrenia

Mike Hennessy Jr
pills
April 30th 2025

April in Review: Updates on the Psychiatric Treatment Pipeline

Leah Kuntz
© 2025 MJH Life Sciences

All rights reserved.